<SEC-DOCUMENT>0001213900-22-062468-index.html : 20221006 <SEC-HEADER>0001213900-22-062468.hdr.sgml : 20221006 <ACCEPTANCE-DATETIME>20221006160135 ACCESSION NUMBER: 0001213900-22-062468 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20221006 FILED AS OF DATE: 20221006 DATE AS OF CHANGE: 20221006 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NLS Pharmaceutics Ltd. CENTRAL INDEX KEY: 0001783036 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39957 FILM NUMBER: 221298159 BUSINESS ADDRESS: STREET 1: THE CIRCLE 6 STREET 2: 8058 CITY: ZURICH STATE: V8 ZIP: CH-6370 BUSINESS PHONE: 41-41-618-80-00 MAIL ADDRESS: STREET 1: THE CIRCLE 6 STREET 2: 8058 CITY: ZURICH STATE: V8 ZIP: CH-6370 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>ea166819-6k_nlspharma.htm <DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER <TEXT> Document 1 - file: ea166819-6k_nlspharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ea166819ex99-1_nlspharma.htm <DESCRIPTION>NOTICE OF MEETING AND PROXY CARD FOR THE ORDINARY SHAREHOLDERS' MEETING TO BE HELD ON OCTOBER 27, 2022 <TEXT> Document 2 - file: ea166819ex99-1_nlspharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>3 <FILENAME>ea166819ex99-2_nlspharma.htm <DESCRIPTION>PRESS RELEASE TITLED: "NLS PHARMACEUTICS ANNOUNCES RECEIPT OF STAFF DELISTING DETERMINATION FROM NASDAQ; INTENDS TO REQUEST HEARING." <TEXT> Document 3 - file: ea166819ex99-2_nlspharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>ex99-1_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: ex99-1_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>ex99-1_002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: ex99-1_002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>ex99-2_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: ex99-2_001.jpg
</DOCUMENT> </SEC-DOCUMENT>